chartexchange

KPTI
Karyopharm Therapeutics Inc.
stockNASDAQ

At CloseNov 10, 2026
0.0174USD-56.500%(-0.0226)146,821,550
Loading…
Loading…
394,657
Healthcare
Biotechnology
CEO
Michael Kauffman
HQ
Newton, MA, USA
Previous Close
$0.04
Beta
2.87
52-Week High
$10.99 2026-02-24
52-Week Low
$0.02 2026-11-10
SMA 50
$0.96
SMA 200
$5.81
Avg. Vol 10D
46.48M
Avg. Vol 30D
16.72M
Avg. Vol 90D
6.67M
Relative Vol
8.78
14.82M
15.6900%
362,517
Feb 26, 2025 · 1-for-15 (reverse)
KPTI Profile

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com

KPTI Performance
PeriodPriceDateChangeBeta
1W0.042026-11-09-56.50%0.000
1M0.392026-10-16-95.54%8.115
3M1.812026-08-17-99.04%6.134
6M7.672026-05-15-99.77%3.683
1Y5.792025-11-17-99.70%2.867
2Y12.212024-11-15-99.86%—
5Y129.152021-11-16-99.99%0.467
KPTI Stock Summary

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) stock price today is $0.02, and today's volume is 146,821,550. The 30 day average volume is 16.72M. KPTI market cap is $394,657 with 22.68M shares outstanding.